Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1863

1.

Non-Hermitian Phase Transition from a Polariton Bose-Einstein Condensate to a Photon Laser.

Hanai R, Edelman A, Ohashi Y, Littlewood PB.

Phys Rev Lett. 2019 May 10;122(18):185301. doi: 10.1103/PhysRevLett.122.185301.

PMID:
31144881
2.

Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study.

Ohno S, Mukai H, Narui K, Hozumi Y, Miyoshi Y, Yoshino H, Doihara H, Suto A, Tamura M, Morimoto T, Zaha H, Chishima T, Nishimura R, Ishikawa T, Uemura Y, Ohashi Y.

Breast Cancer Res Treat. 2019 May 21. doi: 10.1007/s10549-019-05276-y. [Epub ahead of print]

PMID:
31115845
3.

Analysis of Clostridium cluster XI bacteria in human feces.

Ohashi Y, Fujisawa T.

Biosci Microbiota Food Health. 2019;38(2):65-68. doi: 10.12938/bmfh.18-023. Epub 2018 Dec 7.

4.

Can Lipofuscin Deposition on Renal Allograft Tubular Epithelium Be a Surrogate Marker for Kidney Allograft Aging?

Kawaguchi Y, Oguchi H, Mikami T, Yamaguchi Y, Ohashi Y, Kawamura T, Muramatsu M, Itabashi Y, Shinoda K, Hyodo Y, Takahashi Y, Onishi H, Arai T, Hamasaki Y, Shibuya K, Shishido S, Sakai K.

Transplant Proc. 2019 Jun;51(5):1343-1347. doi: 10.1016/j.transproceed.2019.03.017. Epub 2019 May 7.

PMID:
31076149
5.

Donor-Recipient Body Weight Mismatch May Affect Glomerular Basement Membrane Thinning in Electron Microscopic Examination of 1-Hour Renal Allograft Biopsy Specimens.

Kawaguchi Y, Oguchi H, Mikami T, Yamaguchi Y, Kawamura T, Muramatsu M, Itabashi Y, Shinoda K, Hyodo Y, Takahashi Y, Onishi H, Arai T, Ohashi Y, Hamasaki Y, Shibuya K, Shishido S, Sakai K.

Transplant Proc. 2019 Jun;51(5):1348-1352. doi: 10.1016/j.transproceed.2019.01.144. Epub 2019 May 7.

PMID:
31076147
6.

A conserved CCM complex promotes apoptosis non-autonomously by regulating zinc homeostasis.

Chapman EM, Lant B, Ohashi Y, Yu B, Schertzberg M, Go C, Dogra D, Koskimäki J, Girard R, Li Y, Fraser AG, Awad IA, Abdelilah-Seyfried S, Gingras AC, Derry WB.

Nat Commun. 2019 Apr 17;10(1):1791. doi: 10.1038/s41467-019-09829-z.

7.

Analysis of 2897 hospitalization events for patients with chronic kidney disease: results from CKD-JAC study.

Iimuro S, Kaneko T, Ohashi Y, Watanabe T, Nitta K, Akizawa T, Matsuo S, Imai E, Makino H, Hishida A; CKD-JAC Investigators.

Clin Exp Nephrol. 2019 Jul;23(7):956-968. doi: 10.1007/s10157-019-01730-9. Epub 2019 Apr 9.

PMID:
30968244
8.

Diagnostic Performance of Blood Pressure Measurement Modalities in Living Kidney Donor Candidates.

Armanyous S, Ohashi Y, Lioudis M, Schold JD, Thomas G, Poggio ED, Augustine JJ.

Clin J Am Soc Nephrol. 2019 May 7;14(5):738-746. doi: 10.2215/CJN.02780218. Epub 2019 Apr 4.

PMID:
30948455
9.

Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis.

Shoji J, Ohashi Y, Fukushima A, Miyazaki D, Uchio E, Takamura E, Fujishima H, Namba K, Kumagai N, Ebihara N, Okamoto S.

Curr Eye Res. 2019 Apr 5:1-10. doi: 10.1080/02713683.2019.1600197. [Epub ahead of print]

PMID:
30947551
10.

Registration-directed phase 1/2 trial of irinotecan for pediatric solid tumors.

Makimoto A, Mugishima H, Taga T, Ishida Y, Nagatoshi Y, Ida K, Kumagai M, Kimura T, Ohashi Y, Kaneko M.

Pediatr Int. 2019 May;61(5):453-458. doi: 10.1111/ped.13826. Epub 2019 May 14.

PMID:
30859690
11.

Low-dose l-isoproterenol versus salbutamol in hospitalized pediatric patients with severe acute exacerbation of asthma: A double-blind, randomized controlled trial.

Katsunuma T, Fujisawa T, Maekawa T, Akashi K, Ohya Y, Adachi Y, Hashimoto K, Mizuno M, Imai T, Oba MS, Sako M, Ohashi Y, Nakamura H.

Allergol Int. 2019 Mar 5. pii: S1323-8930(19)30014-0. doi: 10.1016/j.alit.2019.02.001. [Epub ahead of print]

12.

Plasma ctDNA monitoring during epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor treatment in patients with EGFR-mutant non-small cell lung cancer (JP-CLEAR trial).

Usui K, Yokoyama T, Naka G, Ishida H, Kishi K, Uemura K, Ohashi Y, Kunitoh H.

Jpn J Clin Oncol. 2019 Jun 1;49(6):554-558. doi: 10.1093/jjco/hyz023.

13.

Tapered arrangement of metallic nanorod chains for magnified plasmonic nanoimaging.

Ohashi Y, Ranjan B, Saito Y, Umakoshi T, Verma P.

Sci Rep. 2019 Feb 25;9(1):2656. doi: 10.1038/s41598-019-39624-1.

14.

Absolute risk score for stroke, myocardial infarction, and all cardiovascular disease: Japan Arteriosclerosis Longitudinal Study.

Harada A, Ueshima H, Kinoshita Y, Miura K, Ohkubo T, Asayama K, Ohashi Y; Japan Arteriosclerosis Longitudinal Study Group.

Hypertens Res. 2019 Apr;42(4):567-579. doi: 10.1038/s41440-019-0220-z. Epub 2019 Feb 13.

PMID:
30760890
15.

Observational study of first-line chemotherapy including cetuximab in patients with metastatic colorectal cancer: CORAL trial.

Muro K, Itabashi M, Hashida H, Masuishi T, Bando H, Denda T, Yamanaka T, Ohashi Y, Sugihara K.

Jpn J Clin Oncol. 2019 Apr 1;49(4):339-346. doi: 10.1093/jjco/hyy189.

16.

Differences Between Patient-Reported Versus Clinician-Observed Nonulcerative Signs and Symptoms of the Foot in Patients With Diabetes Mellitus.

Takehara K, Oe M, Ohashi Y, Tsunemi Y, Kadowaki T, Sanada H.

J Wound Ostomy Continence Nurs. 2019 Mar/Apr;46(2):113-116. doi: 10.1097/WON.0000000000000504.

PMID:
30747799
17.

Real-world outcomes of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS).

Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Minematsu K, Miyamoto S, Murakawa Y, Takeichi M, Ohashi Y, Okayama Y, Sunaya T, Yamanaka S.

J Cardiol. 2019 Jul;74(1):60-66. doi: 10.1016/j.jjcc.2019.01.001. Epub 2019 Feb 8.

PMID:
30745002
18.

Vasa recta hyalinosis reflects severe arteriolopathy in renal allografts.

Oguchi H, Sakai K, Yamaguchi Y, Mikami T, Nemoto T, Ohashi Y, Kawamura T, Muramatsu M, Itabashi Y, Shinoda K, Hyodo Y, Takahashi Y, Kawaguchi Y, Onishi H, Hamasaki Y, Shibuya K, Shishido S.

Clin Exp Nephrol. 2019 Jun;23(6):799-806. doi: 10.1007/s10157-019-01709-6. Epub 2019 Feb 8.

PMID:
30734165
19.

Association between Prescription and Control Status of Dyslipidemia and Hypertension among Japanese Patients with Diabetes.

Sakamoto M, Edo N, Takahashi S, Okamura E, Uno K, Morita K, Ishikawa T, Asahi K, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Kimura K, Ohashi Y, Watanabe T, Tsukamoto K.

J Atheroscler Thromb. 2019 Feb 6. doi: 10.5551/jat.47597. [Epub ahead of print]

20.

Investigation of Material Constants of CaTiO₃ Doped (K,Na)NbO₃ Film by MEMS-Based Test Elements.

Kaneko R, Kadota M, Ohashi Y, Kushibiki JI, Ikeuchi S, Tanaka S.

Micromachines (Basel). 2018 Oct 29;9(11). pii: E558. doi: 10.3390/mi9110558.

21.

Impact of diastolic blood pressure threshold for the young population: the Japan Arteriosclerosis Longitudinal Study (JALS).

Asayama K, Kinoshita Y, Watanabe S, Ohkubo T, Ando T, Harada A, Ohashi Y, Ueshima H, Imai Y; Japan Arteriosclerosis Longitudinal Study (JALS) group.

J Hypertens. 2019 Mar;37(3):652-653. doi: 10.1097/HJH.0000000000002025. No abstract available.

PMID:
30702497
22.

Optimal follow-up intervals for different stages of chronic kidney disease: a prospective observational study.

Hirano K, Kobayashi D, Kohtani N, Uemura Y, Ohashi Y, Komatsu Y, Yanagita M, Hishida A.

Clin Exp Nephrol. 2019 May;23(5):613-620. doi: 10.1007/s10157-018-01684-4. Epub 2019 Jan 28.

23.

Prospective analysis of the association between skeletal-related events and quality of life in patients with advanced lung cancer (CSP-HOR13).

Kunikane H, Yokota I, Katakami N, Takeda K, Takayama K, Sawa T, Saito H, Harada M, Yokota S, Ando K, Saito Y, Ohashi Y, Eguchi K.

Oncol Lett. 2019 Jan;17(1):1320-1326. doi: 10.3892/ol.2018.9680. Epub 2018 Nov 9.

24.

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site.

Hayashi H, Kurata T, Takiguchi Y, Arai M, Takeda K, Akiyoshi K, Matsumoto K, Onoe T, Mukai H, Matsubara N, Minami H, Toyoda M, Onozawa Y, Ono A, Fujita Y, Sakai K, Koh Y, Takeuchi A, Ohashi Y, Nishio K, Nakagawa K.

J Clin Oncol. 2019 Mar 1;37(7):570-579. doi: 10.1200/JCO.18.00771. Epub 2019 Jan 17.

PMID:
30653423
25.

Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study.

Kaji R, Imai T, Iwasaki Y, Okamoto K, Nakagawa M, Ohashi Y, Takase T, Hanada T, Shimizu H, Tashiro K, Kuzuhara S.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):451-457. doi: 10.1136/jnnp-2018-319294. Epub 2019 Jan 13.

26.

A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients.

Watanabe T, Yagata H, Saito M, Okada H, Yajima T, Tamai N, Yoshida Y, Takayama T, Imai H, Nozawa K, Sangai T, Yoshimura A, Hasegawa Y, Yamaguchi T, Shimozuma K, Ohashi Y.

PLoS One. 2019 Jan 9;14(1):e0208118. doi: 10.1371/journal.pone.0208118. eCollection 2019.

27.

A method of producing genetically manipulated mouse mammary gland.

Tagaya H, Ishikawa K, Hosokawa Y, Kobayashi S, Ueoka Y, Shimada M, Ohashi Y, Mikami H, Yamamoto M, Ihara T, Kumazawa K, Sugihara K, Goshima N, Watanabe S, Semba K.

Breast Cancer Res. 2019 Jan 5;21(1):1. doi: 10.1186/s13058-018-1086-8.

28.

Development of clearance verification equipment for uranium-bearing waste.

Yokoyama K, Ohashi Y.

Appl Radiat Isot. 2019 Mar;145:19-23. doi: 10.1016/j.apradiso.2018.11.002. Epub 2018 Nov 16.

PMID:
30572261
29.

Response by Kimura et al to Letters Regarding Article, "High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial".

Kimura T, Iimuro S, Taguchi I, Iwata H, Inoue T, Ohashi Y, Nagai R.

Circulation. 2018 Dec 4;138(23):2728-2729. doi: 10.1161/CIRCULATIONAHA.118.036944. No abstract available.

PMID:
30571270
30.

Deep-learning classification using convolutional neural network for evaluation of maxillary sinusitis on panoramic radiography.

Murata M, Ariji Y, Ohashi Y, Kawai T, Fukuda M, Funakoshi T, Kise Y, Nozawa M, Katsumata A, Fujita H, Ariji E.

Oral Radiol. 2018 Dec 11. doi: 10.1007/s11282-018-0363-7. [Epub ahead of print]

PMID:
30539342
31.

REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients.

Shitara K, Yamanaka T, Denda T, Tsuji Y, Shinozaki K, Komatsu Y, Kobayashi Y, Furuse J, Okuda H, Asayama M, Akiyoshi K, Kagawa Y, Kato T, Oki E, Ando T, Hagiwara Y, Ohashi Y, Yoshino T.

Ann Oncol. 2019 Feb 1;30(2):259-265. doi: 10.1093/annonc/mdy526.

PMID:
30508156
32.

Metabolomics Platform with Capillary Electrophoresis Coupled with High-Resolution Mass Spectrometry for Plasma Analysis.

Sasaki K, Sagawa H, Suzuki M, Yamamoto H, Tomita M, Soga T, Ohashi Y.

Anal Chem. 2019 Jan 15;91(2):1295-1301. doi: 10.1021/acs.analchem.8b02994. Epub 2018 Dec 24.

PMID:
30500154
33.

A pilot study of the clinical evidence for the methodology for prevention of oral mucositis during cancer chemotherapy by measuring salivary excretion of 5-fluorouracil.

Kumagai A, Iijima S, Nomiya T, Furuya I, Ohashi Y, Tsunoda K, Onodera K, Tsunoda N, Komatsu Y, Hirano T.

BDJ Open. 2018 Nov 23;4:17041. doi: 10.1038/s41405-018-0008-2. eCollection 2018.

34.

Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan.

Yoh K, Takamochi K, Shukuya T, Hishida T, Tsuboi M, Sakurai H, Goto Y, Yoshida K, Ohde Y, Okumura S, Ohashi Y, Kunitoh H.

Jpn J Clin Oncol. 2019 Jan 1;49(1):63-68. doi: 10.1093/jjco/hyy165.

PMID:
30452719
35.

Preoperative gastric residual volumes in fasted patients measured by bedside ultrasound: a prospective observational study.

Ohashi Y, Walker JC, Zhang F, Prindiville FE, Hanrahan JP, Mendelson R, Corcoran T.

Anaesth Intensive Care. 2018 Nov;46(6):608-613.

PMID:
30447671
36.

Taxonomic classification for microbiome analysis, which correlates well with the metabolite milieu of the gut.

Wakita Y, Shimomura Y, Kitada Y, Yamamoto H, Ohashi Y, Matsumoto M.

BMC Microbiol. 2018 Nov 16;18(1):188. doi: 10.1186/s12866-018-1311-8.

37.

Sleep Quality and Sleep Duration with CKD are Associated with Progression to ESKD.

Yamamoto R, Shinzawa M, Isaka Y, Yamakoshi E, Imai E, Ohashi Y, Hishida A; CKD-JAC Investigators.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1825-1832. doi: 10.2215/CJN.01340118. Epub 2018 Nov 15.

PMID:
30442866
38.

Usefulness of an unstable board balance test to accurately identify community-dwelling elderly individuals with a history of falls.

Akizuki K, Echizenya Y, Kaneno T, Ohashi Y.

J Rehabil Med. 2019 Jan 1;51(1):71-76. doi: 10.2340/16501977-2504.

39.

VPS34 complexes from a structural perspective.

Ohashi Y, Tremel S, Williams RL.

J Lipid Res. 2019 Feb;60(2):229-241. doi: 10.1194/jlr.R089490. Epub 2018 Nov 5.

40.

Cohort study exploring the effect of lenvatinib on differentiated thyroid cancer.

Tahara M, Takami H, Ito Y, Sugino K, Takahashi S, Takeyama H, Tsutsui H, Hara H, Mitsuma A, Yamashita H, Okamoto T, Sugitani I, Ohashi Y, Imai T.

Endocr J. 2018 Nov 29;65(11):1071-1074. doi: 10.1507/endocrj.EJ18-0261. Epub 2018 Oct 24.

41.

Walking activity in community-dwelling stroke survivors within 1 month after discharge from a rehabilitation setting.

Nakano W, Ohashi Y, Saito Y, Maezawa T, Kohno Y.

Disabil Rehabil. 2018 Oct 20:1-6. doi: 10.1080/09638288.2018.1515268. [Epub ahead of print]

PMID:
30345817
42.

Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA CLinical Evidence on Renal Survival in CKD patients with renal anemia (MIRACLE-CKD Study).

Hayashi T, Uemura Y, Kumagai M, Kimpara M, Kanno H, Ohashi Y; MIRACLE-CKD Study Group.

Clin Exp Nephrol. 2019 Mar;23(3):349-361. doi: 10.1007/s10157-018-1649-0. Epub 2018 Oct 5.

43.

Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).

Shima Y, Nakanishi K, Sako M, Saito-Oba M, Hamasaki Y, Hataya H, Honda M, Kamei K, Ishikura K, Ito S, Kaito H, Tanaka R, Nozu K, Nakamura H, Ohashi Y, Iijima K, Yoshikawa N; Japanese Study Group of Kidney Disease in Children (JSKDC).

Pediatr Nephrol. 2019 May;34(5):837-846. doi: 10.1007/s00467-018-4099-8. Epub 2018 Oct 3.

PMID:
30284023
44.

A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32).

Kusano M, Aoyama T, Okabayashi K, Hirata K, Tsuji Y, Nakamori S, Asahara T, Ohashi Y, Yoshikawa T, Sakamoto J, Oba K, Saji S.

J Cancer Res Ther. 2018 Sep;14(Supplement):S761-S766. doi: 10.4103/0973-1482.179188.

45.

Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.

Iwata H, Masuda N, Yamamoto Y, Fujisawa T, Toyama T, Kashiwaba M, Ohtani S, Taira N, Sakai T, Hasegawa Y, Nakamura R, Akabane H, Shibahara Y, Sasano H, Yamaguchi T, Sakamaki K, Bailey H, Cherbavaz DB, Jakubowski DM, Sugiyama N, Chao C, Ohashi Y.

Breast Cancer Res Treat. 2019 Jan;173(1):123-133. doi: 10.1007/s10549-018-4964-y. Epub 2018 Sep 21.

46.

Evaluation of dynamic change in regenerated tendons in a mouse model.

Ohashi Y, Nakase J, Shimozaki K, Torigoe K, Tsuchiya H.

J Exp Orthop. 2018 Sep 21;5(1):37. doi: 10.1186/s40634-018-0152-6.

47.

Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.

Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, Ito S, Yamamoto T, Tomino Y, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H, Ohtsu H, Ohashi Y; FEATHER Study Investigators.

Am J Kidney Dis. 2018 Dec;72(6):798-810. doi: 10.1053/j.ajkd.2018.06.028. Epub 2018 Sep 1.

48.

Dynamic balance assessment using an unstable board in community-dwelling elderly people.

Akizuki K, Echizenya Y, Kaneno T, Yabuki J, Ohashi Y.

J Phys Ther Sci. 2018 Aug;30(8):1086-1091. doi: 10.1589/jpts.30.1086. Epub 2018 Aug 7.

49.

[Development of New Digital Phantom Creation Tool for Evaluation of Low-contrast Detectability Using Iterative Reconstruction].

Harada K, Ohashi Y, Chiba A, Numasawa K, Imai T, Hayasaka S, Katagiri Y.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74(8):769-778. doi: 10.6009/jjrt.2018_JSRT_74.8.769. Japanese.

50.

Correction to: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.

Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.

Clin Exp Nephrol. 2019 Jan;23(1):99. doi: 10.1007/s10157-018-1624-9.

PMID:
30094596

Supplemental Content

Loading ...
Support Center